Advanced lipid technology

@article{Maeda2017AdvancedLT,
  title={Advanced lipid technology},
  author={N. Maeda and K. Ikeda and M. Matsumoto and Y. Namba},
  journal={Journal of Liposome Research},
  year={2017},
  volume={27},
  pages={221 - 227}
}
Abstract Phospholipids and cholesterols are being spotlighted as raw materials for preparing liposomes, one of the key compounds for drug delivery systems (DDS), and as base compounds for converting water-soluble drugs to fat-soluble drugs. Other applications of phospholipids also are being explored. Nippon Fine Chemical, aware of the future of such lipids, has developed new processes for synthesizing and purifying phospholipids and is supplying them on an industrial scale. These products… Expand
3 Citations

References

SHOWING 1-10 OF 10 REFERENCES
Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate.
1-O-Palmityl-D-glucuronate Endows Liposomes with Long Half-Life In Vivo
Glucuronate-modified liposomes with prolonged circulation time.
A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy.
Tumor accumulation of novel RES-avoiding liposomes.
Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
Antineovascular therapy with angiogenic vessel‐targeted polyethyleneglycol‐shielded liposomal DPP–CNDAC
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Chuusyazai (Tokusyu Seizai) (Injections (specialty formulations)): Zaikei to Seizaihou (Dosage forms and formulation methods)
  • Itai S, ed. Handbook of pharmaceutical machinery and engineering
  • 2010